Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...

Scientists have discovered a potential new treatment for familial hypercholesterolemia, inspired by signs seen in the Mona ...

Millions of individuals rely on effective medications to manage diseases like cancer and diabetes. For those with chronic myeloid leukemia (CML), advancements in treatment selection could ...

In recent years, artificial intelligence (AI) has revolutionized the healthcare industry, accelerating the pace of medical ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

Manas AI secures funding led by General Catalyst to scale AI-driven drug discovery, tackling cancer and rare diseases.

Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

Manas AI, a full-stack, AI-driven company focused on discovering and advancing next generation medicines, launched today. By leveraging its ...

These hallucinations—moments when AI generates outputs untethered from reality—have been seen as problems to correct. But ...

“AI is redefining what’s possible in medicine, and the establishment ... advanced AI platforms alongside traditional research, Rakovina aims to significantly reduce the time and cost associated with ...

Insilico Medicine (“Insilico”), a clinical ... of artificial intelligence in the acceleration of target discovery and drug repurposing. AI has simplified target identification and improved ...